日韩精品久久一区二区三区_亚洲色图p_亚洲综合在线最大成人_国产中出在线观看_日韩免费_亚洲综合在线一区

Global EditionASIA 中文雙語(yǔ)Fran?ais
World
Home / World / China-US

China-US cooperation combating breast cancer launched

chinadaily.com.cn | Updated: 2018-06-26 11:44
Share
Share - WeChat

The breast cancer center of Guangdong Academy of Medical Sciences & Guangdong General Hospital has recently been recognized by the National Surgical Adjuvant Breast and Bowel Project (NSABP) from the US as its first official partner in China.

The latest inclusion was announced at the 2018 China-America Summit Forum on Surgical Oncology and 2018 China-America Summit Forum on Breast Cancer in Guangzhou, capital city of south Guangdong province in mid June.

Liao Ning delivers a presentation at the 3rd China-America Summit Forum on Breast Cancer in Guangzhou on Jun 16. [provided to chinadaily.com.cn]

Liao Ning, head of the center said: "As an NSABP affiliated member, we can participate in more global research in breast cancer and better present Chinese patients in international researches in a bid to advance treatment and prevention of the disease worldwide," she said.

China reported more than 260,000 new cases of breast cancer annually, accounting for about 15 percent of all new cases of cancer every year, statistics from the Chinese National Central Cancer Registry showed.

The data from Chinese patients is crucial for cancer drug research and development internationally as well, she said.

"The cooperation will be of mutual benefits for both sides and represents a start of wider and deepen collaboration in the future to better contain breast cancer," she said.

Charles Balch, President of the International Sentinel Node Society and former executive vice president and CEO of the American Society of Clinical Oncology, said: "This brings China in as a full partner at the world stage to do clinical trials globally with NSAPB."

Liao and her team would have access into the global clinical trials with investigators worldwide and “her data from China would contribute to global research and clinical trials of breast cancer, he explained.

According to Balch, NSABP had seen over the past two years the quality and excellence of the breast cancer care and research at the center and deter and decided to include it as its affiliated member.

Liao Ning (center) and foreign delegates at the forum [Provided to chinadaily.com.cn]

"And I hope it will be so successful that other major projects doing breast cancer clinical trials in China would apply to be approved as NSABP affiliated members as well," he added.

In March, Liao Ning was elected as the International Director of the American Society of Oncology Surgery, which means that the hospital has been in line with international standards in the surgical treatment of breast cancer, including axillary sentinel lymph node biopsy, breast conserving breast surgery and breast reconstruction, according to Geng Qingshan, Party Secretary of Guangdong General Hospital.

"The hospital will vigorously support the follow-up cooperation between the breast cancer center led by Liao and international research and clinical organizations, and jointly explore a scientific and comprehensive multidisciplinary treatment model to benefit more breast cancer patients," he said.

Regarding the latest NSABP inclusion, Geng said: "In April 2018, our hospital submitted the application and after strict examination, we became China's first NSABP member of the main research unit. This is the result of our joint efforts.

I hope that we will continue to deepen cooperation and jointly promote human health in the future."

As the clinical intervention of breast cancer enters into the new stage of targeting therapy and precision medicine, “international cooperation and data sharing is of greater importance for better treatment and cancer drug research and development,” said Liao Ning, who has been committed to breast cancer surgical treatment for nearly 30 years.

The National Surgical Adjuvant Breast and Bowel Project (NSABP) based in the US is a clinical trials cooperative group supported since its inception by the US National Cancer Institute.

It has a more than 50-year history of designing and conducting clinical trials that have changed the way breast cancer is treated, and, more recently, prevented.

Notably, it was the NSABP's breast cancer studies that led to the establishment of lumpectomy plus radiation over radical mastectomy as the standard surgical treatment for breast cancer worldwide.

Headquartered in Pittsburgh, Pennsylvania, it has research sites at nearly 1000 major medical centers, university hospitals, large oncology practice groups, and health maintenance organizations in the US, Canada, Puerto Rico, Australia, and Ireland.

At those sites and their satellites, more than 5000 physicians, nurses, and other medical professionals conduct NSABP treatment and prevention trials.

Most Viewed in 24 Hours
Top
BACK TO THE TOP
English
Copyright 1995 - . All rights reserved. The content (including but not limited to text, photo, multimedia information, etc) published in this site belongs to China Daily Information Co (CDIC). Without written authorization from CDIC, such content shall not be republished or used in any form. Note: Browsers with 1024*768 or higher resolution are suggested for this site.
License for publishing multimedia online 0108263

Registration Number: 130349
FOLLOW US
主站蜘蛛池模板: 久操精品在线观看 | 欧美一区二区视频 | 亚洲成a人片在线观看www流畅 | 第一福利在线观看 | 亚洲网站色 | 亚洲天堂视频在线免费观看 | 国产精品区一区二区三 | 在线日韩精品视频 | 久草视频手机在线观看 | 欧美性免费视频 | 欧美日韩一区二区高清视 | 视频一区二区在线观看 | 亚洲一区二区三区首页 | 欧美视频在线免费播放 | 99久久99热这里只有精品 | 欧美电影网 在线电影 | 成人亚洲视频在线观看 | 狠狠澡夜夜澡人人爽 | 亚洲天堂免费视频 | 国产美女自拍视频 | a久久| 99精品视频在线观看re | 国产亚洲欧美视频 | 夜夜夜久久久 | 国产AV亚洲精品久久久久 | 国产精品不卡一区 | 日韩欧美在线免费观看视频 | 久久精品二 | 国产日产在线观看 | 亚洲精品一区中文字幕乱码 | 亚洲成a人片在线观看www流畅 | 国产专区一区 | 自拍偷拍亚洲欧美 | 久久精品道一区二区三区 | 蜜臀影院 | 亚洲欧洲av在线 | 另类国产ts人妖高潮系列视频 | 久草免费小视频 | 奇米在线影视 | 最近免费日本视频在线 | 青青青青手机在线视频观看国产 |